{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:57:02Z","timestamp":1794956222771,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ24H310002"],"award-info":[{"award-number":["LZ24H310002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116491","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:55:59Z","timestamp":1711446959000},"page":"116491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Oxymatrine alleviates high-fat diet\/streptozotocin-induced non-alcoholic fatty liver disease in C57BL\/6\u202fJ mice by modulating oxidative stress, inflammation and fibrosis"],"prefix":"10.1016","volume":"174","author":[{"given":"Di","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8459-3315","authenticated-orcid":false,"given":"Minyou","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116491_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.phrs.2018.01.015","article-title":"Natural products for the treatment of type 2 diabetes mellitus: pharmacology and mechanisms","volume":"130","author":"Xu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"18","key":"10.1016\/j.biopha.2024.116491_bib2","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.biopha.2024.116491_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116491_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116491_bib5","first-page":"284","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet\u00a0Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116491_bib6","first-page":"578","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet\u00a0Dastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116491_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1039\/D0FO02335C","article-title":"Icariin ameliorates streptozocin-induced diabetic nephropathy through suppressing the TLR4\/NF-\u03baB signal pathway","volume":"12","author":"Qi","year":"2021","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.biopha.2024.116491_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biom12091227","article-title":"Oxidative stress and NRF2\/KEAP1\/ARE pathway in diabetic kidney disease (DKD): new perspectives","volume":"12","author":"Tanase","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116491_bib9","doi-asserted-by":"crossref","first-page":"1112363","DOI":"10.3389\/fendo.2023.1112363","article-title":"The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116491_bib10","first-page":"3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res. 2020"},{"issue":"24","key":"10.1016\/j.biopha.2024.116491_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116491_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","article-title":"NLRP3 at the interface of metabolism and inflammation","volume":"265","author":"Haneklaus","year":"2015","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116491_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116491_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"10","key":"10.1016\/j.biopha.2024.116491_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102759","article-title":"Cellular and molecular mechanisms underlying liver fibrosis regression","volume":"10","author":"Caligiuri","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2024.116491_bib16","first-page":"217","article-title":"Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-\u03b21\/Smad signaling pathway], Sheng li xue bao","volume":"74","author":"Zhou","year":"2022","journal-title":"Acta Physiol. Sin."},{"key":"10.1016\/j.biopha.2024.116491_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.603476","article-title":"Efficacy and safety of Sophora flavescens (Kushen) based traditional Chinese medicine in the treatment of ulcerative colitis: clinical evidence and potential mechanisms","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116491_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jep.2015.06.010","article-title":"Sophora flavescens Ait.: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine","volume":"172","author":"He","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116491_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jep.2018.06.019","article-title":"In vivo and in vitro anti-inflammatory effects of Sophora flavescens residues","volume":"224","author":"Ma","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116491_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104541","article-title":"Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: from bench to bedside","volume":"151","author":"Lan","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116491_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12250-019-00088-2","article-title":"Oxymatrine inhibits bocavirus MVC replication, reduces viral gene expression and decreases apoptosis induced by viral infection","volume":"34","author":"Ding","year":"2019","journal-title":"Virol. Sin."},{"issue":"6","key":"10.1016\/j.biopha.2024.116491_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.phymed.2014.02.007","article-title":"Hypoglycemic and hypolipidemic effects of oxymatrine in high-fat diet and streptozotocin-induced diabetic rats","volume":"21","author":"Guo","year":"2014","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.biopha.2024.116491_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fphar.2020.00548","article-title":"Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era?","volume":"11","author":"Chan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116491_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118090","article-title":"Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease","volume":"257","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116491_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fphar.2020.00216","article-title":"Hepatic proteomic changes and Sirt1\/AMPK signaling activation by oxymatrine treatment in rats with non-alcoholic steatosis","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116491_bib26","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1111\/bph.14482","article-title":"Nuciferine ameliorates hepatic steatosis in high-fat diet\/streptozocin-induced diabetic mice through a PPAR\u03b1\/PPAR\u03b3 coactivator-1\u03b1 pathway","volume":"175","author":"Zhang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116491_bib27","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1021\/acsnano.9b02050","article-title":"Gadofullerene nanoparticles reverse dysfunctions of pancreas and improve hepatic insulin resistance for type 2 diabetes mellitus treatment","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biopha.2024.116491_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2024.116491_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101382","article-title":"Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4\/NF-kB inflammatory pathway and oxidative stress in T2DM\/NAFLD rats","volume":"66","author":"Xu","year":"2020","journal-title":"Tissue Cell"},{"key":"10.1016\/j.biopha.2024.116491_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.568861","article-title":"SIRT1 Antagonizes oxidative stress in diabetic vascular complication","volume":"11","author":"Meng","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.116491_bib31","doi-asserted-by":"crossref","first-page":"3096470","DOI":"10.1155\/2020\/3096470","article-title":"Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation","volume":"2020","author":"Robles-Rivera","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.biopha.2024.116491_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tem.2017.02.008","article-title":"Nutrient sensing and the oxidative stress response","volume":"28","author":"Luo","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2024.116491_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0284185120922135","article-title":"The effect of computed tomography on oxidative stress level and some antioxidant parameters","volume":"62","author":"G\u00fcnd\u00fcz","year":"2021","journal-title":"Acta Radiol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116491_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162082","article-title":"Oxidative stress, DNA damage and DNA repair in female patients with diabetes mellitus type 2","volume":"11","author":"Grindel","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2024.116491_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/molecules22040439","article-title":"Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of moringa oleifera in diabetes-induced nephrotoxic male wistar rats","volume":"22","author":"Omodanisi","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116491_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108306","article-title":"Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1\/AMPK signaling","volume":"104","author":"Liang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116491_bib37","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"7761","key":"10.1016\/j.biopha.2024.116491_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2024.116491_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1165\/rcmb.2015-0231TR","article-title":"Regulation and function of the nucleotide binding domain leucine-rich repeat-containing receptor, pyrin domain-containing-3 inflammasome in lung disease","volume":"54","author":"Lee","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116491_bib40","article-title":"The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116491_bib41","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.12659\/MSM.903269","article-title":"Function of NLRP3 in the pathogenesis and development of diabetic nephropathy","volume":"23","author":"Fu","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"18","key":"10.1016\/j.biopha.2024.116491_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.21037\/atm.2019.09.03","article-title":"The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus","volume":"7","author":"Leng","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.116491_bib43","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116491_bib44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116491_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153294","article-title":"Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-\u03b2\/Smad and YAP signaling","volume":"78","author":"Xiang","year":"2020","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116491_bib46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.30252","article-title":"NLR Family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice","volume":"69","author":"Inzaugarat","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116491_bib47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/DDDT.S215949","article-title":"Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-\u03b2\/Smad signaling pathway [Corrigendum]","volume":"13","author":"Mu","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116491_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pharep.2017.11.017","article-title":"Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: oxidative stress\/TGF-\u03b2(1)-induced HSCs activation pathway","volume":"70","author":"Atallah","year":"2018","journal-title":"Pharmacol. Rep.: PR"},{"issue":"3","key":"10.1016\/j.biopha.2024.116491_bib49","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10753-019-00973-8","article-title":"Umbelliferone ameliorates CCl(4)-induced liver fibrosis in rats by upregulating PPAR\u03b3 and attenuating oxidative stress, inflammation, and TGF-\u03b21\/Smad3 signaling","volume":"42","author":"Mahmoud","year":"2019","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.biopha.2024.116491_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174008","article-title":"Prevention of TGF-\u03b2-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:15:43Z","timestamp":1782342943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S0753332224003755"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116491","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxymatrine alleviates high-fat diet\/streptozotocin-induced non-alcoholic fatty liver disease in C57BL\/6\u202fJ mice by modulating oxidative stress, inflammation and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116491"}}